Biomena - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 299,853 | 171,270 | 179,836 | 193,540 | 294,260 | 190,880 | 264,120 | 282,490 |
| Profit before tax | 116,515 | 49,810 | 79,411 | 60,090 | 59,345 | 53,784 | 114,424 | 29,497 |
| Net profit | 110,689 | 47,319 | 75,440 | 57,085 | 56,377 | 51,095 | 108,703 | 26,457 |
| Equity | 233,289 | 280,608 | 356,048 | 413,133 | 469,510 | 520,605 | 629,308 | 655,765 |
| Liabilities | 5,876 | 20,901 | 3,971 | 14,890 | 59,817 | 3,922 | 10,367 | 9,584 |
| Non-current assets | 0 | 0 | 0 | 313,775 | 313,775 | 313,775 | 340,410 | 340,410 |
| Current assets | 239,165 | 301,509 | 360,019 | 114,248 | 215,552 | 210,752 | 299,265 | 324,939 |
| Total assets | 239,165 | 301,509 | 360,019 | 428,023 | 529,327 | 524,527 | 639,675 | 665,349 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 58,490 | 48,316 | 130,043 |
|
Financial indicators
|
||||||||
| Revenue change y/y | 0.0% | -42.9% | +5.0% | +7.6% | +52.0% | -35.1% | +38.4% | +7.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 46.3% | 15.7% | 21.0% | 13.3% | 10.7% | 9.7% | 17.0% | 4.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 47.4% | 16.9% | 21.2% | 13.8% | 12.0% | 9.8% | 17.3% | 4.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 36.9% | 27.6% | 41.9% | 29.5% | 19.2% | 26.8% | 41.2% | 9.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 38.9% | 29.1% | 44.2% | 31.0% | 20.2% | 28.2% | 43.3% | 10.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 149,927 | 85,635 | 89,918 | 96,770 | 147,130 | 95,440 | 132,060 | 141,245 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biomena - Social security debts
The company had no debts to Sodra
Biomena - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-17 | 2025-05-19 | 21168.6 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biomena, UAB (code 304562705) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €282.5K, up 7.0% year on year and 48.0% higher than two years earlier. Net profit reached €26.5K, which was materially below the €108.7K reported in 2024 but still above the €51.1K achieved in 2023. This means profitability weakened in 2025 after a very strong 2024, with the net profit margin falling to 9.4% from 41.2% a year earlier. The balance sheet remained solid, with total assets of €665.3K, equity of €655.8K and liabilities of only €9.6K. The equity ratio was 98.6%, debt-to-equity stood at 0.01, and asset turnover was 0.42x. Revenue per employee was €141.2K and profit per employee €13.2K, indicating a small but productive operation.